Alimera Sciences Executives
Alimera Sciences employs about 154 people. The company is managed by 9 executives with a total tenure of roughly 25 years, averaging almost 2.0 years of service per executive, having 17.11 employees per reported executive. Analysis of Alimera Sciences' management performance can provide insight into the firm performance.
Alimera |
Alimera Sciences Management Team Effectiveness
Alimera Sciences' management efficiency ratios could be used to measure how well Alimera Sciences manages its routine affairs as well as how well it operates its assets and liabilities.Alimera Sciences Workforce Comparison
Alimera Sciences is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 5,581. Alimera Sciences holds roughly 154 in number of employees claiming about 2.76% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.15) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.08 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.08. Alimera Sciences Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Alimera Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Alimera Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Alimera Sciences insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Jones John Philip over six months ago Acquisition by Jones John Philip of 8750 shares of Alimera Sciences subject to Rule 16b-3 | ||
Morgan Adam over six months ago Disposition of 7000 shares by Morgan Adam of Alimera Sciences at 1.7 subject to Rule 16b-3 | ||
Morgan Adam over six months ago Disposition of 6000 shares by Morgan Adam of Alimera Sciences at 2.1 subject to Rule 16b-3 | ||
Richard Eiswirth over a year ago Acquisition by Richard Eiswirth of 500 shares of Alimera Sciences at 4.437 subject to Rule 16b-3 | ||
Maltz Elliot over a year ago Acquisition by Maltz Elliot of 75000 shares of Alimera Sciences subject to Rule 16b-3 | ||
Wood Todd Michael over a year ago Acquisition by Wood Todd Michael of 125000 shares of Alimera Sciences subject to Rule 16b-3 | ||
John Snisarenko over a year ago Acquisition by John Snisarenko of 50000 shares of Alimera Sciences subject to Rule 16b-3 | ||
Skibsted Russell over a year ago Acquisition by Skibsted Russell of 58000 shares of Alimera Sciences subject to Rule 16b-3 |
Alimera Sciences Notable Stakeholders
An Alimera Sciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Alimera Sciences often face trade-offs trying to please all of them. Alimera Sciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Alimera Sciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| David Holland | Co-Founder and Sr. VP of Sales and Marketing | Profile | |
| Todd Wood | President Operations | Profile | |
| Richard Eiswirth | Pres and CFO | Profile | |
| Elliot CPA | CFO Treasurer | Profile | |
| Christopher Visick | General VP | Profile | |
| Philip Ashman | Sr. VP and European Managing Director | Profile | |
| Jason Werner | Chief Officer | Profile | |
| Charles Myers | NonEx Consultant | Profile | |
| David MD | Chief Specialist | Profile |
Alimera Sciences Workforce Analysis
Traditionally, organizations such as Alimera Sciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Alimera Sciences within its industry.Alimera Sciences Manpower Efficiency
Return on Alimera Sciences Manpower
| Revenue Per Employee | 524.4K | |
| Revenue Per Executive | 9M | |
| Net Loss Per Employee | 130.7K | |
| Net Loss Per Executive | 2.2M | |
| Working Capital Per Employee | 198.1K | |
| Working Capital Per Executive | 3.4M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Alimera Stock
If you are still planning to invest in Alimera Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alimera Sciences' history and understand the potential risks before investing.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |